We came across a bullish thesis on Sanofi (SNY) on Substack by Business Model Mastery. In this article, we will summarize the ...

The patient, Michael Anthony John Caselberg, a 53-year-old British expat, presented at Aster Cedars Hospital and Clinic, ...

Apogee Therapeutics, Inc. had promising results from its APG808 Phase 1b study show potential for every 2-month asthma ...

Apogee expects to continue incurring increased expenses as it advances its programs through clinical trials, seeks marketing ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

More than 30 per cent of UAE residents suffer from acid reflux, a common digestive issue that can progress to ...

Phathom Pharmaceuticals has shot up ~50% in Friday trading after the disclosure that a member of its board made a significant ...

In a phase 3 trial Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions. It was found that ...

Phathom Pharmaceuticals, Inc.’s PHAT share price has surged by 32.75%, which has investors questioning if this is right time to sell.

While sunshine and speakeasies haven't been known to mix, for one day only, Corona is bringing speakeasies into the sunlight ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology designed to optimize drug delivery for applications with significant unmet need, ...

Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third ...